文献速递关节外科

围手术期他汀使用或降低全关节置换术后心律失常发生率

Perioperative Statin Use May Reduce Postoperative Arrhythmia Rates After Total Joint Arthroplasty.
PubMed 文献 · J Arthroplasty · 2021-05-25

BACKGROUND: Postoperative arrhythmias are associated with increased morbidity and mortality in total joint arthroplasty (TJA) patients.…

要点

  • 围手术期辛伐他汀80mg/d使全关节置换术后90天心律失常风险相对降低约10倍。
  • 绝对风险降低3.6%,约治疗28例未用他汀患者可预防1例术后心律失常。

核心结论

  • 围手术期使用辛伐他汀可能降低初次全关节置换术后90天新发心律失常的发生率。

研究设计与样本

  • 单中心回顾性队列研究,231例初次全关节置换患者(109髋、122膝)住院期间按单术者标准方案每日服用辛伐他汀80mg,与966例未服用辛伐他汀的初次全关节置换患者(387髋、579膝)匹配。

主要发现

  • 围手术期他汀使术后90天心律失常相对风险降低约10倍,绝对风险降低3.6%。

关键数值与推荐

  • 新发心律失常包括心动过缓、心房颤动/心动过速/扑动、阵发性室上性心动过速和室性心动过速。
  • 研究把握度设定为检测心律失常率3%的差异。
  • 每治疗28例未用他汀的全关节置换患者可预防1例术后90天新发心律失常。

临床怎么用

  • 对未使用他汀的初次全关节置换患者,可考虑围手术期使用辛伐他汀80mg/d以降低术后90天心律失常风险。

局限性

  • 单中心回顾性队列设计,非随机分组,可能存在残余混杂。
  • 研究仅涉及辛伐他汀80mg/d方案,结果外推至其他他汀或剂量需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Postoperative arrhythmias are associated with increased morbidity and mortality in total joint arthroplasty (TJA) patients. HMG-CoA (3-hydroxy-3-methyl-glutaryl-CoA) reductase inhibitors (statins) decrease atrial fibrillation rates after cardiac surgery, but it is unknown if this cardioprotective effect is maintained after joint reconstruction surgery. We aim to determine if perioperative statin use decreases the incidence of 90-day postoperative arrhythmias in patients undergoing primary TJA. METHODS: We performed a single-center retrospective cohort study in which 231 primary TJA patients (109 hips, 122 knees) received simvastatin 80 mg daily during their hospitalization as part of a single surgeon's standard postoperative protocol. This cohort was matched to 966 primary TJA patients (387 hips and 579 knees) that did not receive simvastatin. New-onset arrhythmias (bradycardia, atrial fibrillation/tachycardia/flutter, paroxysmal supraventricular tachycardia, and ventricular tachycardia) and complications (readmissions, thromboembolism, infection, and dislocation) within 90 days of the procedure were documented. Categorical variables were analyzed using Fisher's exact tests. Our study was powered to detect a 3% difference in arrhythmia rates. RESULTS: Within 90 days postoperatively, arrhythmias occurred in 1 patient (0.4%) who received a perioperative statin, 39 patients (4.0%) who did not receive statins (P = .003), and 24 patients (4.2%) who were on outpatient statins (P = .005). This is 10-fold reduction in the relative risk of developing a postoperative arrhythmia within 90 days of arthroplasty and an absolute risk reduction of 3.6%. CONCLUSION: Treating as few as 28 patients with perioperative simvastatin prevents one new cardiac arrhythmia within 90 days in statin-naïve patients undergoing TJA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Bonano JC, Aratani AK, Sambare TD, et al. Perioperative Statin Use May Reduce Postoperative Arrhythmia Rates After Total Joint Arthroplasty. J Arthroplasty. 2021. PMID: 34127349. doi:10.1016/j.arth.2021.05.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。